SYNAPTIVE MEDICAL INC.

Profile

Company Names

SYNAPTIVE MEDICAL INC.

Addresses

555 RICHMOND STREET W, SUITE 800, TORONTO, A6 M5V 3B1

101 COLLEGE STREET, SUITE 200, TORONTO, A6 M5G 1L7

Phone Numbers

647-925-3435
416-673-6679

 

Entity Type:

CORPORATION

Industry:

OTHER HEALTH CARE, BIOTECHNOLOGY

Year Incorporated:

2012

State Incorporated:

ONTARIO, CANADA

Total Amount Raised:

$34,537,886.00

Number of Funding Rounds:

9
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
9
2019-03-26 
$4,993,688.00 
$4,993,688.00 
$0.00 
Debt 
8
2018-11-28 
$5,006,312.00 
$5,006,312.00 
$0.00 
Debt 
7
2017-06-30 
$14,218,191.00 
$14,218,191.00 
$0.00 
Equity 
6
2016-12-23 
$901,256.00 
$901,256.00 
$0.00 
Equity 
5
2016-09-24 
$3,428,905.00 
$3,428,905.00 
$0.00 
Equity 
4
2016-02-12 
$910,741.00 
$910,741.00 
$0.00 
Equity 
3
2015-12-15 
$2,089,857.00 
$2,089,857.00 
$0.00 
Equity 
2
2015-06-05 
$2,101,853.00 
$2,101,853.00 
$0.00 
Equity 
1
2014-11-21 
$887,083.00 
$887,083.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RICHARD 
 
BUTLAND 
DIRECTOR
SANDRA 
 
CLARKE 
EXECUTIVE OFFICER
JAMES 
 
CLOAR 
EXECUTIVE OFFICER
JAMES 
L. 
CLOAR 
EXECUTIVE OFFICER
GEORGE 
PETER 
DANS 
EXECUTIVE OFFICER
PETER 
 
DANS 
EXECUTIVE OFFICER
MICHAEL 
 
DEMANE 
DIRECTOR
DAVID 
 
GALLOP 
EXECUTIVE OFFICER, DIRECTOR
DAVID 
BRUCE 
GALLOP 
EXECUTIVE OFFICER, DIRECTOR
WESLEY 
 
HODGES 
EXECUTIVE OFFICER, DIRECTOR
DOUG 
 
JANZEN 
DIRECTOR
DOUGLAS 
GLEN 
JANZEN 
DIRECTOR
VINCENT 
 
LUCIANI 
EXECUTIVE OFFICER
CAMERON 
 
PIRON 
EXECUTIVE OFFICER, DIRECTOR
WILLIAM 
PATRICK 
RYAN 
EXECUTIVE OFFICER
GAL 
 
SELA 
EXECUTIVE OFFICER, DIRECTOR
GLENN 
DANIEL 
STEELE JR. 
DIRECTOR
PETER 
 
WEHRLY 
DIRECTOR
PETER 
LEE 
WEHRLY 
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2019-03-26 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2018-11-28 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-06-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-12-23 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-09-24 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-09-24 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-02-12 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-15 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-05 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-11-21 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#